Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases
Elisabeth Bergen(Medical University of Vienna), Rupert Bartsch(Universitätszahnklinik Wien), Florian Fitzal, Michael Gnant(Austrian Breast & Colorectal Cancer Study Group), Anna S. Berghoff(Medical University of Vienna), Guenther G. Steger(Mount Vernon Hospital), Karin Dieckmann(University of Vienna), Matthias Preusser(Medical University of Vienna), Margaretha Rudas(Comprehensive Cancer Center Vienna), Ruth Exner(Comprehensive Cancer Center Vienna), Christoph Zielinski(Vienna General Hospital), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Robert M. Mader(Centre de Recherche en Économie et Management), Mela Medjedovic(Comprehensive Cancer Center Vienna)
Cited by 46
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Breast cancer
|The Lancet|2016|2.3k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
|Journal of Clinical Oncology|2010|1.6k